Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Pfizer Inc.’s next-generation treatment for breast cancer posted mixed results in a final-stage study, a potential setback ...

Revenues came in at $17.76 billion, up 22% from the year-ago quarter. Higher sales of Pfizer’s key non-COVID products like Vyndaqel, Padcev and Eliquis and newly acquired products from Seagen ...

Pfizer's disclosure Friday that it is ending ... undisclosed development and commercialization milestones for the product along with royalties on product sales. The exact amount of the payments ...